Primary Site >> Esophagus Cancer

Gene >> PDPN

  • 2004
  • 2007
  • 2008
  • 2013
  • 2014
  • 2015
  • 2017
  • 2018
Ref: [Current diagnosis and therapy of esophageal carcinoma].
PMID: 15248111
Ref: Significance of lymphangiogenesis as assessed by immunohistochemistry for podoplanin in patients with esophageal carcinoma.
PMID: 17348451
Ref: Acceleration of the proliferative activity of esophageal carcinoma with invasion beyond the muscularis mucosae; immunohistochemical analysis using MIB-1 for the Ki-67 antigen.
PMID: 21318949
Ref: Value of endoscopic ultrasound staging in conjunction with the evaluation of lymphovascular invasion in identifying low-risk esophageal carcinoma.
PMID: 18072264
Ref: Lymphangiogenesis and lymphovascular invasion diminishes prognosis in esophageal cancer.
PMID: 23294880
Ref: Esophagectomy for failed endoscopic therapy in patients with high-grade dysplasia or intramucosal carcinoma.
PMID: 23795720
Ref: Podoplaninpositive cancer cells at the edge of esophageal squamous cell carcinomas are involved in invasion.
PMID: 24938315
Ref: Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries.
PMID: 26185366
Ref: Prognostic value of vascular endothelial growth factor-C and podoplanin mRNA expression in esophageal cancer.
PMID: 26788189
Ref: SIX1 maintains tumor basal cells via transforming growth factor-beta pathway and associates with poor prognosis in esophageal cancer.
PMID: 27987372
Ref: Performance of 18-fluoro-2-deoxyglucose positron emission tomography for esophageal cancer screening.
PMID: 28487611
Ref: Using the National Cancer Database to create a scoring system that identifies patients with early-stage esophageal cancer at risk for nodal metastases.
PMID: 28867381
Ref: Expression of Cat Podoplanin in Feline Squamous Cell Carcinomas.
PMID: 29090969
Ref: Endoscopic Treatment of Early-Stage Esophageal Cancer.
PMID: 30058019